Dezső Csupor

Prof. Dr. Dezső Csupor

Institute of Clinical Pharmacy, University of Szeged, Faculty of Pharmacy, Szeged, Csongrád, Hungary
+2
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2012 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
STSimplice Joel Ndendoung Tatsimo
Simplice Joel Ndendoung Tatsimo
TDTamokou Jean De Dieu
Tamokou Jean De Dieu
LHLéopold Havyarimana
Léopold Havyarimana
Dezső CsuporDezső Csupor
Dezső Csupor
PFPeter Forgo
Peter Forgo
PTPierre Tane
Pierre Tane
Bryophyllum pinnatum (Lank.) Oken (Crassulaceae) is a perennial succulent herb widely used in traditional medicine to treat many ailments. Its wide range of uses in folk medicine justifies its being called "life plant" or "resurrection plant", prompting researchers' interest. We describe here the isolation and structure elucidation of antimicrobial and/or antioxidant components from the EtOAc extract of B. pinnatum.

20 August 2012 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
AVAndrea Vasas
Andrea Vasas
Dóra RédeiDóra Rédei
Dóra Rédei
Dezső CsuporDezső Csupor
Dezső Csupor
JMJoseph Molnár
Joseph Molnár
JHJudit Hohmann
Judit Hohmann

14 February 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
DDDalma Dobszai
Dalma Dobszai
PMPéter Mátrai
Péter Mátrai
ZGZoltán Gyöngyi
Zoltán Gyöngyi
Dezső CsuporDezső Csupor
Dezső Csupor
JBJudit Bajor
Judit Bajor
OGon behalf of the Hungarian Pancreatic Study Group
on behalf of the Hungarian Pancreatic Study Group
Body-mass index correlates with severity and mortality in acute pancreatitis: A meta-analysis

1 October 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Dezső CsuporDezső Csupor
Dezső Csupor
ACAttila Csorba
Attila Csorba
JHJudit Hohmann
Judit Hohmann

23 July 2018 in Planta Medica
Verified
Journal Article
Open access
PDF file
BTBarbara Tóth
Barbara Tóth
PHPéter Hegyi
Péter Hegyi
Tamás LantosTamás Lantos
Tamás Lantos
ZSZsolt Szakács
Zsolt Szakács
BKBeáta Kerémi
Beáta Kerémi
Dezső CsuporDezső Csupor
Dezső Csupor
Herbal products, especially Hypericum perforatum extracts, have been widely used as first-line treatments for mild to moderate depression. Recently, several randomized, controlled clinical trials have been conducted to evaluate the efficacy of another plant, saffron (Crocus sativus), in mild to moderate depression. We have carried out a literature review of currently available published randomized, controlled clinical trials to give an up-to-date evaluation of the efficacy of saffron in mild to moderate depression, compared to placebo or routinely used antidepressants. The meta-analysis is reported according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines using the PICO (patients, intervention, comparison, outcome) format and was conducted using the statistical programs Comprehensive Meta-analysis and RevMan. PubMed, Embase, the Cochrane Central Register of Controlled Trials, and Web of Science databases were searched for relevant studies. Only placebo or active controlled, randomized clinical studies involving patients suffering from mild to moderate depression and using pharmacological doses of saffron per os were included. Hedgesʼ g was used to calculate effect sizes. Risk of bias was assessed using the Cochrane Collaboration tool, and heterogeneity was tested by both performing the Cochranʼs Q test and calculating Higginsʼ I2 indicator. Eleven randomized trials were included in the qualitative analysis, and nine were pooled for statistical analysis. According to the present meta-analysis, saffron has a significant effect on the severity of depression. Available data from randomized, controlled clinical trials support that saffron is significantly more effective than placebo (g = 0.891; 95% CI: 0.369 – 1.412, p = 0.001), and non-inferior to tested antidepressant drugs (g = − 0.246; 95% CI: − 0.495 – 0.004, p = 0.053).

19 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FMFanni Adél Meznerics
Fanni Adél Meznerics
PFPeter Fehérvári
Peter Fehérvári
FDFanni Dembrovszky
Fanni Dembrovszky
KKKata Dorottya Kovács
Kata Dorottya Kovács
LKLajos Kemeny
Lajos Kemeny
BABanvolgyi Andras
Banvolgyi Andras
Background: Chronic wounds place a heavy burden on the healthcare system due to the prolonged, continuous need for human resources for wound management. Our aim was to investigate the therapeutic effects of platelet-rich plasma on the treatment of chronic wounds. Methods: The systematic literature search was performed in four databases. Randomized clinical trials reporting on patients with chronic wounds treated with platelet-rich plasma (PRP) were included, comparing PRP with conventional ulcer therapy. We pooled the data using the random effects model. Our primary outcome was the change in wound size. Results: Our systematic search provided 2688 articles, and we identified 48 eligible studies after the selection and citation search. Thirty-three study groups of 29 RCTs with a total of 2198 wounds showed that the odds for complete closure were significantly higher in the PRP group than in the control group (OR = 5.32; CI: 3.37; 8.40; I2 = 58%). Conclusions: PRP is a safe and effective modality to enhance wound healing. By implementing it in clinical practice, platelet-rich plasma could become a widely used, valuable tool as it could not only improve patients’ quality of life but also decrease the healthcare burden of wound management.